Deborah Konkol
Saint Louis, MONPI 1659395606
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 27.2% of the total.
Across 151 payments — averaging $16.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$660
- Biohaven Pharmaceuticals, Inc.$237
- Mayne Pharma Commercial LLC$201
- Biohaven Pharmaceutical Holding Company Ltd.$187
- Astellas Pharma US Inc$130
- Lupin Inc.$91
- plus $921 from 22 others
What the payments were for
- Food & beverage$2,34797%
- Education$813%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $660 |
| Biohaven Pharmaceuticals, Inc. | 9 | $237 |
| Mayne Pharma Commercial LLC | 16 | $201 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $187 |
| Astellas Pharma US Inc | 5 | $130 |
| Lupin Inc. | 6 | $91 |
| Mission Pharmacal Company | 5 | $80 |
| Therapeuticsmd, Inc. | 6 | $80 |
| Vertical Pharmaceuticals, LLC | 6 | $79 |
| Merck | 5 | $67 |
| Lilly USA, LLC | 5 | $65 |
| Avion Pharmaceuticals | 3 | $64 |
| Novo Nordisk | 4 | $63 |
| Evofem Biosciences, Inc. | 3 | $52 |
| Amgen | 3 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 |
| AMAG Pharmaceuticals, Inc. | 2 | $44 |
| Mylan Pharmaceuticals Inc. | 2 | $43 |
| Organon | 3 | $35 |
| Sage Therapeutics, LLC | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
| Bayer | 1 | $20 |
| Dysis Medical, Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Gilead | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Agile Therapeutics, Inc. | 1 | $12 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$235
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.